Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
756,674
+35,365
+5% +$63.8K 0.12% 121
2025
Q4
$1.33M Buy
721,309
+52,238
+8% +$90.8K 0.15% 115
2025
Q3
$1.07M Buy
669,071
+101,028
+18% +$185K 0.24% 62
2025
Q2
$988K Buy
568,043
+99,336
+21% +$166K 0.12% 114
2025
Q1
$1.12M Buy
468,707
+15,572
+3% +$51K 0.14% 113
2024
Q4
$1.6M Buy
453,135
+7,001
+2% +$27.7K 0.2% 107
2024
Q3
$1.89M Sell
446,134
-82,251
-16% -$356K 0.22% 96
2024
Q2
$1.98M Buy
528,385
+143,387
+37% +$653K 0.23% 102
2024
Q1
$2.09M Buy
384,998
+74,224
+24% +$428K 0.24% 103
2023
Q4
$1.92M Buy
310,774
+48,138
+18% +$237K 0.25% 89
2023
Q3
$1.36M Buy
262,636
+3,615
+1% +$19.3K 0.2% 104
2023
Q2
$1.3M Sell
259,021
-1,223
-0.5% -$4.96K 0.18% 105
2023
Q1
$958K Buy
260,244
+68,171
+35% +$257K 0.14% 113
2022
Q4
$691K Buy
+192,073
New +$1.01M 0.1% 120

Other funds holding OABI

Isthmus Partners's OABI Position: Q1 2026 in Review

Isthmus Partners increased its OmniAb (OABI) stake by 4.9% in Q1 2026, buying an estimated $63.8K and bringing the position to 756,674 shares worth $1.19M. The position accounts for 0.12% of the portfolio, ranked #121.

Isthmus Partners first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.09M in Q1 2024. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Isthmus Partners held 756,674 shares of OmniAb worth $1.19M as of Q1 2026.
  • Isthmus Partners bought 35,365 OmniAb shares in Q1 2026, an estimated $63.8K.
  • OmniAb made up 0.12% of Isthmus Partners's portfolio in Q1 2026, its #121 holding.
  • Isthmus Partners first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
  • Isthmus Partners's OmniAb position peaked at $2.09M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Isthmus Partners's 13F filing for Q1 2026, filed 30 Apr 2026.